Author: Piers Townley

Researchers from the University of Texas MD Anderson have discovered an enzyme that helps brain tumours grow in nutrient-starved environments

Yesterday saw the launch of the Less Survivable Cancers Taskforce to an audience of members of the Scottish Parliament in Holyrood, Edinburgh

The University of Cambridge is to begins trials using the Zika virus on glioblastoma, the most common and aggressive form of brain tumour. Glioblastomas affect 2,200 people in the UK each year

The terminal illness charity is looking for applications that address its key research priorities identified by carers, health and social care professionals and people with terminal illness, and particularly, those areas that have until now received the least attention

Researchers from the Nottingham University’s children’s brain tumour centre are now looking into the effects of cannabidiol (CBD), the non-psychoactive ingredient in marijuana

The Brain Tumour Charity CEO, Sarah Lindsell, has co-signed a letter to NHS organisations urging them to meet their one-year survival targets for the early diagnosis of brain tumours.

Trainee neurosurgeon at University Hospital Coventry and Warwickshire, Yasir Chowdhury, shines a light on day-to-day life in one of the most complex and dangerous areas of surgery and shares his hopes for finding a cure for brain tumours

Last week Bristol-Myers Squibb announced the initial results from their Phase 3 clinical trial that was assessing the effectiveness and safety of the immunotherapy drug Nivolumab in patients with recurrent glioblastoma.

BrainPath is a surgical technique that uses the brain’s own tissue folds to tract a path to the tumour site. It is designed to be minimally invasive.

Researchers at McGill University Health Centre (MUHC), Montreal have developed a new clinical approach to enhance the efficiency of treatment for glioblastomas, which increased the average survival time to 22 months.

The Imaging Centre of Excellence (ICE), was opened last Wednesday at the University of Glasgow, with the aim to be a global hub for precision medicine.

Researchers at St. Jude Children’s Research Hospital, USA have revealed how a key protein involved in driving the growth of the most aggressive form of medulloblastoma also plays a role in stopping its development.

Scientists from The Institute of Cancer Research (ICR) have discovered 13 new genetic errors related with an increased risk of developing glioma in one of the largest ever studies of this devastating disease

Construction on the building of one of the UK’s first Proton Beam Therapy (PBT) facilities is well under way at University College London Hospital.

Ahead of the national elections in May 2016 we have launched manifestos in Wales, Northern Ireland and Scotland.

Last week, the UK Government announced changes to the eligibility criteria for Personal Independence Payments (PIP) as part of the 2016 Budget.

The e-petition calls on larger cancer charities and the government to invest more in research into brain tumours.

Paul Nicholson, has won the Healthcare Volunteer of the Year award for his work and commitment to The Brain Tumour Charity, following his own ongoing battle with a low grade brain tumour.

We will use every day of March to make our voice heard, on behalf of everyone everywhere whose life has been affected by a brain tumour.

emotive, a science and technology-led healthcare agency, has chosen us out of 24 charities to be their Team Charity for 2016.

On 27 January, a brain tumour patient at Angers hospital wore a Virtual Reality (VR) headset during an awake craniotomy to allow neurosurgeons to ‘map’ his brain tumour as it was being removed.

The report discovered that up to 63% of 111 English hospital trusts have at least one scanner that is a decade old, the point where the technology ideally should be scrapped and replaced with upgraded machines.

This March we’ll be launching manifestos in Scotland, Wales and Northern Ireland ahead of the devolved nations’ elections in May.

Dr Jem Rashbass, National Director for Disease Registration at Public Health England, has posted a new Public Health England blog about the importance of cancer data.